Response to Letter Regarding Article, "Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT"

被引:0
作者
Bohula, Erin A. [1 ]
Giugliano, Robert P. [1 ]
Cannon, Christopher P. [1 ]
Zhou, Jing [1 ]
Murphy, Sabina A. [1 ]
White, Jennifer [2 ]
Tershakovec, Andrew M. [3 ]
Blazing, Michael A. [2 ]
Braunwald, Eugene [1 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, TIMI Study Grp,Cardiovasc Div,Dept Med, Boston, MA 02115 USA
[2] Duke Clin Res Inst, Durham, NC USA
[3] Merck, Kenilworth, NJ USA
关键词
TRIALS;
D O I
10.1161/CIRCULATIONAHA.116.020947
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E463 / E463
页数:1
相关论文
共 4 条
[1]   Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT [J].
Bohula, Erin A. ;
Giugliano, Robert P. ;
Cannon, Christopher P. ;
Zhou, Jing ;
Murphy, Sabina A. ;
White, Jennifer A. ;
Tershakovec, Andrew M. ;
Blazing, Michael A. ;
Braunwald, Eugene .
CIRCULATION, 2015, 132 (13) :1224-1233
[2]   Creating controversy where none exists: the important role of C-reactive protein in the CARE, AFCAPS/TexCAPS, PROVE IT, REVERSAL, A to Z, JUPITER, HEART PROTECTION, and ASCOT trials [J].
Braunwald, Eugene .
EUROPEAN HEART JOURNAL, 2012, 33 (04) :430-432
[3]   Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes [J].
Cannon, Christopher P. ;
Blazing, Michael A. ;
Giugliano, Robert P. ;
McCagg, Amy ;
White, Jennifer A. ;
Theroux, Pierre ;
Darius, Harald ;
Lewis, Basil S. ;
Ophuis, Ton Oude ;
Jukema, J. Wouter ;
De Ferrari, Gaetano M. ;
Ruzyllo, Witold ;
De Lucca, Paul ;
Im, KyungAh ;
Bohula, Erin A. ;
Reist, Craig ;
Wiviott, Stephen D. ;
Tershakovec, Andrew M. ;
Musliner, Thomas A. ;
Braunwald, Eugene ;
Califf, Robert M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (25) :2387-2397
[4]   Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines [J].
Grundy, SM ;
Cleeman, JI ;
Merz, CNB ;
Brewer, HB ;
Clark, LT ;
Hunninghake, DB ;
Pasternak, RC ;
Smith, SC ;
Stone, NJ .
CIRCULATION, 2004, 110 (02) :227-239